Finance

Beta
Lists
TARA:NASDAQ
Protara Therapeutics Inc
$4.04
+5.76%
(+0.22) 1D
$3.89
-3.71% (-0.15)
After hours
Closed: Jul 1, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TARA...
Open
$3.80
High
$4.04
Low
$3.76
Mkt. cap
227.07M
Avg. vol.
828.71K
Volume
29.00
52-wk high
$7.82
52-wk low
$2.77
EPS
-$1.35
Beta
1.45
Shares outstanding
56.20M
No. of employees
46
Open
$3.80
High
$4.04
Low
$3.76
Mkt. cap
227.07M
Avg. vol.
828.71K
Volume
29.00
52-wk high
$7.82
52-wk low
$2.77
EPS
-$1.35
Beta
1.45
Shares outstanding
56.20M
No. of employees
46
News stories
From sources across the web
About Protara Therapeutics Inc
CEO-
Employees46
Founded2006
Headquarters-
SectorBiotechnology
Websiteprotaratx.com
Analyst ratings
Based on 7 analysts giving stock ratings to TARA in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for TARA in the last 3 months.
Highest
Current $4.04
$28.00 (+593.07%)
Average
$26.00 (+543.56%)
Lowest
$24.00 (+494.06%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brian Cheng
J.P. Morgan
Buy
Maintained
-
-
06/30/2026
Kelsey Goodwin
Piper Sandler
Buy
Maintained
$24.00
+494.1%
05/20/2026
Charles Zhu
LifeSci Capital
Buy
Maintained
$26.00
+543.6%
05/20/2026
Unknown Analyst
Oppenheimer
Buy
Reiterated
$28.00
+593.1%
05/20/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
$28.00
+593.1%
05/20/2026
Stacy Ku
TD Cowen
Buy
Reiterated
-
-
05/20/2026
Andres Y. Maldonado
H.C. Wainwright
Buy
Reiterated
$27.00
+568.3%
05/20/2026
Boris Peaker
JonesTrading
Buy
Reiterated
$25.00
+518.8%
05/19/2026
Soumit Roy
JonesTrading
Buy
Maintained
$25.00
+518.8%
04/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
10.77M
9.59M
13.12M
13.56M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.82M
5.17M
5.96M
6.07M
Operating expense
16.59M
14.76M
19.08M
19.63M
Total operating expenses
16.59M
14.76M
19.08M
19.63M
Operating income
-16.59M
-14.76M
-19.08M
-19.63M
Other non operating income
-
-
249.00K
-
EBT including unusual items
-14.96M
-13.26M
-17.31M
-17.78M
EBT excluding unusual items
-14.96M
-13.26M
-17.31M
-17.78M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-14.96M
-13.26M
-17.31M
-17.78M
Net profit margin
-
-
-
-
Earnings per share
-0.35
-0.31
-0.38
-0.31
Interest and investment income
1.63M
1.50M
1.52M
1.85M
Interest expense
-
-
-
-
Net interest expenses
1.63M
1.50M
1.52M
1.85M
Depreciation and amortization charges
-
-
-
-
EBITDA
-16.49M
-14.67M
-18.99M
-19.54M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer